Combined 75-150μm M1 and 150-300μm [DC-Beadstm] DEB-TACE for Hepatocellular Carcinoma: Single Center Prospective Results
1. Abstract 1.1. Purpose: To report first single center long-term, prospective results in treating HCC with a combined embolization protocol of 75-150μm M1 and 100-300μm DC-BeadsTM as well as toxicity profile and identification of prognostic factors associated with better treatment outcome.